Tag: pharmaceutical stocks

Stocks

Merck Options: Profit as Markets Turn Defensive

Want to profit from Merck’s breakout in a defensive market? This options strategy could unlock big gains. Curious how? Click...

03/09/2025

2 views

Read More

Market News

Eli Lilly’s GLP-1 Pill Shakes Markets: Should You Invest?

Eli Lilly’s GLP-1 pill data sent stocks soaring. Is this a game-changer for investors? Dive into the market buzz and...

26/08/2025

2 views

Read More

Global Markets

US-EU Trade Deal Impacts: What Investors Need to Know

The new US-EU trade deal shakes up markets with tariff changes. Which sectors win, and which lose? Dive into the...

25/08/2025

2 views

Read More

Market News

Obesity Pill Setbacks: What Investors Need to Know

Viking Therapeutics' obesity pill trial data sent its stock plummeting 30%. What went wrong, and what does it mean for...

19/08/2025

2 views

Read More

Buying Opportunities

Insider Buying Signals Bright Future For Eli Lilly Stock

Eli Lilly's CEO and insiders are buying shares after a stock dip. Is this a golden opportunity for investors? Dive...

13/08/2025

3 views

Read More

Market News

Why Eli Lilly’s Stock Drop Is a Hidden Opportunity

Eli Lilly's stock took a hit, but analysts see a silver lining. Is this a chance to buy low? Dive...

08/08/2025

2 views

Read More

Market News

3 Stocks Thriving in a Mixed Market: One to Avoid

Which stocks are winning in today’s shaky market? We dive into 3 top performers and reveal one to avoid. Curious...

07/08/2025

2 views

Read More

Market News

Why Lilly’s Weight-Loss Pill Shook Markets

Lilly’s stock crashed after its weight-loss pill underperformed. But with stellar Q2 results, is this a buying opportunity or a...

07/08/2025

2 views

Read More

Market News

Eli Lilly’s Q2 2025: Mounjaro, Zepbound Drive Growth

Eli Lilly's Q2 2025 earnings beat expectations with blockbuster drug sales. But what’s next for their obesity pill trials? Click...

07/08/2025

2 views

Read More

Market News

Eli Lilly Earnings: What to Expect in Q2 2025

Will Eli Lilly's Q2 earnings soar with Zepbound's success? Analysts predict big wins, but what about CVS's Wegovy move? Click...

06/08/2025

2 views

Read More